2024年世界肺癌大会（WCLC）年会刚刚在美国圣地亚哥落幕。作为全球规模最大的肿瘤领域学术会议之一，WCLC大会发布的最新前沿进展令人目不暇接，内容更是覆盖肺癌领域的方方面面。《肿瘤瞭望》有幸现场采访了IASLC首席执行官Karen Kelly教授和2024 WCLC大会共同主席Sandip Patel教授，邀请两位专家分享2024 WCLC大会热点。

 

Dr.Kelly:2024 WCLC是一次非常特别的WCLC，因为正值IASLC成立50周年。在1974年，当时肺癌在全球正处于爆发阶段（尤其是在男性中，但女性中也同样如此），死亡率确实在飙升，几乎没有治疗方法，如果及早发现，可以通过手术将其切除。当时肺癌没有治愈手段，甚至没有人为了治愈肺癌而展开竞争，因为真的没有人知道该怎么做。但我认为当时有一群非常有远见的研究人员，这些外科医生和肿瘤内科医生大胆地迎接挑战，去改变不可接受的现实。他们知道抗击肺癌应采取多学科方法，需要进行全球合作，因为全球肺癌死亡在上升。他们走到了一起，并于1974年正式成立了IASLC。

 

自那时以来，他们取得了许多进展，只有真正的合作才能找到答案，这就是IASLC的作用所在。如果能为研究人员提供了一个交流的平台，他们永远不会缺少想法。IASLC将他们聚集在一起，因为他们对做某事充满热情，并扮演着重要研究的倡导者的角色，而且他们已经开展了如此多的研究。

 

回想过去，再看看当下的研究进展，你会意识到这是一段前所未有的旅程。当我在1990年代开始工作时，我无法想象肺癌研究能发展到哪一步，我只是对所有的工作感到敬畏。IASLC不仅提供了研究平台，也为世界各地的医生和研究人员提供了教育平台，助力年轻研究人员开始职业生涯。

 

Dr.Kelly:So yes，this is a really special WCLC because we are celebrating 50 years.When you go back to 1974(and just to be clear，I was not involved in the very beginning of this)，it was time in the world when lung cancer was really taking off，particularly in men，but also in women，where the mortality rate was really skyrocketing.At that time，there was really no treatment.If you happened to catch it early，you might have it surgically removed.I always have a phrase that I say that there wasn’t a cure，there wasn’t even a race for a cure，because really no one knew what to do.But there was a group of researchers who I believed so visionary，surgeons and medical oncologists，at that time who boldly decided to take this on-to say that this is not acceptable.But they also knew two things-that it was going to take a multidisciplinary approach，and that it was going to take a global approach，because we were seeing the worldwide mortality rate go up.With that，they got together，and in 1974 they officially formed the International Association for the Study of Lung Cancer.Since that time，they have been so many advances，that the answers can only happen if there is truly collaboration.That is where the IASLC comes in.If you provide researchers a platform to get together，they are never short on ideas.The IASLC brings them together because they are so passionate about doing something and plays the role of advocate for great research.And there has just been tremendously so much research.When you think back then and see what is happening now，it has been an unprecedented journey.When I began in the 1990s，I never would have thought that we would be where we are today.We never had any idea of where we would be.I am just in awe of all the work，and that the IASLC provides a platform for research，but also for education.It brings a platform for educating physicians and researchers around the world，but also young investigators and trying to help jumpstart their career.

 

Dr.Patel：我是加州大学圣地亚哥分校肿瘤内科学教授Sandip Patel医学博士，担任WCLC 2024的共同主席之一。IASLC是一个国际肺癌研究组织。癌症是我们面临的最大难题，就死亡率而言，肺癌是抗癌过程中的最大难题。IASLC从过去到现在不断演化，从收集患者治疗和各种治疗方法的国际数据，到展示所有治疗方式（外科、介入、放射学、病理学、肿瘤内科等）的最新数据，我们成为一个跨专业的国际社区，共同致力于改善患者的治疗效果。在2024 WCLC庆祝IASLC的50周年，提醒我们IASLC的历史就是改善肺癌生存的历史，而致力于改善肺癌生存的历史就是IASLC的历史。

 

Dr Patel:I’m Sandip Patel MD，Professor of Medical Oncology at the University of California San Diego.I am one of the co-Chairs of WCLC 2024 here in San Diego.It is a pleasure to be joining you to discuss the data.

 

IASLC is an international organization.Cancer is the biggest problem that we fight.Lung cancer is the biggest problem within cancer that we fight in terms of mortality.The IASLC has been involved all the way from the initial staging to modern versions，collecting international data that helps us identify patients for treatment，and different therapeutic approaches.This has morphed into the ability to present the latest data across all therapeutic modalities-surgical，interventional，radiology，pathology，medical oncology-and it is ideal that we work together as an international community across specialties to improve outcomes for patients.To celebrate our 50th year at WCLC 2024，it has really been a reminder that the history of the IASLC is the history of improving survival in lung cancer，and the history of survival for lung cancer is the history of the IASLC.

Dr.Kelly:据我们了解，IASLC中国成员非常渴望交流，在好奇心驱动下努力学习，这值得赞赏和重视。参加WCLC是一种参与IASLC的方式，同时可参与IASLC为年轻研究人员设立的学院和国际会员计划，并申请IASLC奖项和研究项目。IASLC确实是唯一设置国际奖项的组织。IASLC为全球各地的成员提供更多机会，因为我们知道拥有这些机会可助力他们的职业生涯，这包括中国成员。下个月我将在香港参加亚洲肺癌会议，这将是见面的好机会；然后前往上海了解那里的工作方式。事实上，我不久前刚在北京度过了一段美好的时光，更重要的是获取了新的知识，以便更好地帮助所有人。

 

IASLC致力于为会员提供更多帮助和价值。我总是扪心自问，IASLC还能做些什么？我重申我个人想做的事情还有很多，但和你们继续建立和维持关系非常重要。

 

Dr.Kelly:I think one of the things we know about our Chinese members，all of whom are appreciated and valued，is that they really do crave this communication and this yearning for learning with their inquisitive minds.So coming to a meeting like this is one way to be involved，but also participating in our Academy that we have for young investigators and our international membership program，and applying for some of our awards and research projects.We truly are the only group that has international awards.We give people across the globe more opportunities because we know that having these types of opportunities help accelerate their careers，and also coming to you in China.That is really important as well.I will be in Hong Kong next month for the Asia Conference on Lung Cancer，and it is going to be a great opportunity to meet with all of you.I will be going from there to Shanghai to discover myself how you work.I was actually just in Beijing not too long ago，and I had a wonderful time.But I am gaining knowledge so that I can better help all of you.We are committed to being more helpful and more valuable.I am always going around to say，what more can we do Again，I am only one person and there is a lot that I want to do，but it is very important that we continue to build relationships and sustain relationships.It has been really fantastic.